Clinical Trials in Chicago

Showing 13241-13260 of 17,609 trials

Asthma Phenotypes in the Inner City

NCT01383941

This is an epidemiologic, multi-center, cross-sectional study to define the phenotypic characteristics of Difficult-to-Treat asthma, among children between the ages of 6 to 17 years, receiving one year of guidelines-based therapy for asthma and rhinitis/rhinosinusitis.

AsthmaRhinitis

National Institute of Allergy and Infectious Diseases (NIAID)717 participantsStarted Aug 2011

Denver, Colorado, United States • Washington D.C., District of Columbia, United States • Chicago, Illinois, United States +6 more locations

COMPLETEDPhase 32.2 miles

Individualized Therapy For Asthma in Toddlers

NCT01606306

The INFANT study will test whether, in preschool children 12-59 months of age with persistent asthma, the following Step 2 asthma therapies will provide similar degrees of asthma control: 1. Daily inhaled corticosteroid (ICS) treatment, 2. Daily leukotriene receptor antagonist (LTRA) treatment, and 3. As-needed ICS plus short-acting beta agonist (as-needed ICS/SABA) rescue treatment.

AsthmaWheezing

Milton S. Hershey Medical Center300 participantsStarted Feb 2013

Tucson, Arizona, United States • Oakland, California, United States • San Francisco, California, United States +10 more locations

Asthma Phenotypes in the Inner City

Individualized Therapy For Asthma in Toddlers

Find Trials by Condition in Chicago

Sutent + Taxol for Advanced Esophageal Cancer

A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases

A Study of Tomato Products and Disease Risk

Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer

An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis

Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)

Pazopanib in Treating Patients With Recurrent Glioblastoma

Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)

Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia

Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects

Vitamin D/Calcium Polyp Prevention Study

Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis

A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients

The Effect of Diflunisal on Familial Amyloidosis

Micro-Layer Ablation of Barrett's Metaplasia- A Two-Phase, Multi-Center Trial - Extension of Follow-up to 5 Years

Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder

Stepped Enhancement of PTSD Services Using Primary Care (STEPS UP): A Randomized Effectiveness Trial

Phase I Study of CBP501 and Cisplatin in Patients With Advanced Refractory Solid Tumors